Literature DB >> 23301322

Statement on Council of Medical Specialty Societies' Code for Interactions with Companies.

.   

Abstract

Mesh：

Year:  2012        PMID： 23301322

Source DB:  PubMed          Journal:  Bull Am Coll Surg        ISSN： 0002-8045


× No keyword cloud information.
  4 in total

1.  We Are Making no Progress.

Authors:  Thomas Lempert
Journal:  Dtsch Arztebl Int       Date:  2016-03-11       Impact factor: 5.594

2.  Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences.

Authors:  Wojtek Wiercioch; Robby Nieuwlaat; Elie A Akl; Robert Kunkle; Kendall E Alexander; Adam Cuker; Anita Rajasekhar; Pablo Alonso-Coello; David R Anderson; Shannon M Bates; Mary Cushman; Philipp Dahm; Gordon Guyatt; Alfonso Iorio; Wendy Lim; Gary H Lyman; Saskia Middeldorp; Paul Monagle; Reem A Mustafa; Ignacio Neumann; Thomas L Ortel; Bram Rochwerg; Nancy Santesso; Sara K Vesely; Daniel M Witt; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-05-26

Review 3.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

4.  Physician and stakeholder perceptions of conflict of interest policies in oncology.

Authors:  A Craig Lockhart; Marcia S Brose; Edward S Kim; David H Johnson; Jeffrey M Peppercorn; Dina L Michels; Courtney D Storm; Lynn M Schuchter; W Kimryn Rathmell
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.